Rebalance Health
PrivateLast Round
Series C
Aug 14, 2023
Est. Valuation
$31.37M
Total Funding Raised
$21.7M
Company Overview
Rebalance Health operates in Healthcare & Life Sciences and is based in Boulder, Colorado. Its latest recorded funding round was a Series C round in August 2023.
Rebalance Health is a health and wellness company that offers products made with nutrients and adaptogens intended to optimize health and fitness by targeting cortisol and hormone levels.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Subscription Commerce, Mental Health, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rebalance Health Comparables
Compare Rebalance Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmavite LLC | 79% | |
| dsm-firmenich | 78% | |
| O Positiv Health | 78% |
For institutional investors. Book with your work email.
Rebalance Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 14, 2023 | ||||
| Series B | May 6, 2022 | ||||
| Series A | Nov 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rebalance Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ALMA Life Sciences | Series B, Series A |
| The Ropart Asset Management Funds | Series B, Series A |
| Sage Venture Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 56% MoM to 7.3K.
- Mar 7, 2025
Launched the Rebalance Anxiety System to promote calm and focus.
For institutional investors. Book with your work email.
Rebalance Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rebalance Health's valuation, stock price, and market status.
Is Rebalance Health a public or private company?
Rebalance Health is a private company.
What is the current stock price of Rebalance Health?
Rebalance Health is a private company, so its shares have no public market price. Caplight tracks Rebalance Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rebalance Health worth (valuation)?
Rebalance Health's valuation is estimated at $31.4M based on funding round data.
Can I buy Rebalance Health stock?
Rebalance Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rebalance Health's last funding round?
Rebalance Health's most recent funding round was Series C on August 14, 2023.
Who are the main investors in Rebalance Health?
Key investors in Rebalance Health include ALMA Life Sciences, The Ropart Asset Management Funds, Sage Venture Partners.
Will Rebalance Health IPO soon?
No public IPO plans have been announced for Rebalance Health.
How can I track Rebalance Health secondary market activity?
Caplight tracks bids, offers, and trades in Rebalance Health's shares on secondary markets.